4//SEC Filing
Svoronos Dawn 4
Accession 0000950170-24-069462
CIK 0001582313other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 5:41 PM ET
Size
14.8 KB
Accession
0000950170-24-069462
Insider Transaction Report
Form 4
Graham Dawn
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-05+15,542→ 15,542 totalExercise: $38.16Exp: 2034-06-04→ Common Shares (15,542 underlying)
Footnotes (1)
- [F1]Vesting 100% on the earlier of (i) June 4, 2025 or (ii) the day before the date of the issuer's 2025 annual meeting of shareholders.
Issuer
Xenon Pharmaceuticals Inc.
CIK 0001582313
Entity typeother
Related Parties
1- filerCIK 0001574579
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 5:41 PM ET
- Size
- 14.8 KB